SCHEMBL644517

SCHEMBL644517

CN(Cc1ccccn1)S(=O)(=O)c1cc(-c2nnc(O)n2-c2ccccc2Cl)c(O)cc1O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 4/20 0.49
ALDH1A1 P00352 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
PDK1 Q15118 1/20 0.36
HSD17B10 Q99714 1/20 0.36
LMNA P02545 1/20 0.36
PKM P14618 1/20 0.36
SLC12A2 P55011 1/20 0.36
SLC12A5 Q9H2X9 1/20 0.36
CCR6 P51684 1/20 0.35
RORC P51449 1/20 0.34
NPSR1 Q6W5P4 1/20 0.33
CYBB P04839 1/20 0.33
CYP3A4 P08684 1/20 0.33
NOX4 Q9NPH5 1/20 0.33
NOX1 Q9Y5S8 1/20 0.33
KDM4E B2RXH2 1/20 0.33
GLA P06280 1/20 0.33
MAPT P10636 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL646674 0.91 HSP90AA1 (0.43) HSP90AA1HSD17B10RORCKDM4EGLA
SCHEMBL646663 0.91 HSP90AA1 (0.47) HSP90AA1ALDH1A1SMN1; SMN2
SCHEMBL648090 0.90 HSP90AA1 (0.49) HSP90AA1ALDH1A1SMN1; SMN2
SCHEMBL647317 0.90 HSP90AA1 (0.52) HSP90AA1SMN1; SMN2HSD17B10RORCKDM4E
SCHEMBL646642 0.87 HSP90AA1 (0.52) HSP90AA1ALDH1A1SMN1; SMN2LMNARORC
SCHEMBL646966 0.87 HSP90AA1 (0.52) HSP90AA1ALDH1A1LMNAMAPT
SCHEMBL646372 0.86 HSP90AA1 (0.50) HSP90AA1ALDH1A1PDK1LMNACYP3A4
SCHEMBL645773 0.86 HSP90AA1 (0.48) HSP90AA1ALDH1A1LMNAPKM
SCHEMBL4933407 0.86 HSP90AA1 (0.55) HSP90AA1ALDH1A1SMN1; SMN2HSD17B10LMNA
SCHEMBL646667 0.85 HSP90AA1 (0.51) HSP90AA1ALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2023922-B1 TRIAZOLE DERIVATIVES II MERCK PATENT GMBH (DE) 2012-07-11 EP claimed
US-8119795-B2 Triazole derivatives II MERCK PATENT GMBH (DE) 2012-02-21 US claimed
US-20100022540-A1 TRIAZOLE DERIVATIVES II MERCK PATENT GESELLSCHAFT (DE) 2010-01-28 US claimed
EP-2023922-B1 TRIAZOLE DERIVATIVES II MERCK PATENT GMBH (DE) 2012-07-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100022540-A1 TRIAZOLE DERIVATIVES II HSP90AB1, HSP90AA1, HSP90AB2P HSP90AA1 2/4885ALDH1A1 1671/4885SMN1; SMN2 3736/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.